Fused heterocyclic kinase inhibitors

In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.

Saved in:
Bibliographic Details
Main Authors ZHEN-WEI CAI, ROBERT M. BORZILLERI, WAYNE VACCARO, XIAO TAO CHEN, TRAM N. HUYNH, ZHONG CHEN, KYOUNG S. KIM
Format Patent
LanguageEnglish
Published 12.01.2006
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
AbstractList In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
Author ZHEN-WEI CAI
TRAM N. HUYNH
KYOUNG S. KIM
ROBERT M. BORZILLERI
WAYNE VACCARO
XIAO TAO CHEN
ZHONG CHEN
Author_xml – fullname: ZHEN-WEI CAI
– fullname: ROBERT M. BORZILLERI
– fullname: WAYNE VACCARO
– fullname: XIAO TAO CHEN
– fullname: TRAM N. HUYNH
– fullname: ZHONG CHEN
– fullname: KYOUNG S. KIM
BookMark eNrjYmDJy89L5WRQcSstTk1RyEgtSS3KT65MzslMVsjOzEssTlXIzMvITMosyS8q5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgYGpkZmQMLM0dCYOFUArdMpmA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2005260056A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2005260056A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:57:40 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2005260056A13
Notes Application Number: AU20050260056
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060112&DB=EPODOC&CC=AU&NR=2005260056A1
ParticipantIDs epo_espacenet_AU2005260056A1
PublicationCentury 2000
PublicationDate 20060112
PublicationDateYYYYMMDD 2006-01-12
PublicationDate_xml – month: 01
  year: 2006
  text: 20060112
  day: 12
PublicationDecade 2000
PublicationYear 2006
RelatedCompanies BRISTOL-MYERS SQUIBB COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB COMPANY
Score 2.6357477
Snippet In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Fused heterocyclic kinase inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060112&DB=EPODOC&locale=&CC=AU&NR=2005260056A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTYHtumB1bSuQYphkq5JalKibqJhqqluarK5uaVhmhEolYBWW_iZeYSaeEWYRjAx5MD2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1eO8YmFyN1FycbF0D_F38ndWcnYE9STW_IPCJm6Cz2E3NHIF9JVZgQ9oclB9cw5xA-1IKkCsVN0EGtgCgeXklQgxMqXnCDJzOsLvXhBk4fKFT3kAmNPcVizCouJUWp6YoZIBWsOQnVyYDnaqQnZkHrIcUMvMyMpMyQTfniDIou7mGOHvoAq2Lh_su3jEU2W3GYgwswH5_qgSDQlqScUqipUkysKuYZGJimZaUaAxsL5kkm5lZmpumGqVIMsjgM0kKv7Q0AxdsNMHQSIaBpaSoNFUWWL-WJMmBgwUALAh9Ig
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQVH34q2TVv6MGTrB1W3bkgnextNmrKidMN2iP-9l7LOPe0tJJAv7nL3S-5-AegyC316NNPKU6JShXAaK7HKDYUzy7LVVBNSIqItQjOYkteZMWvAV50LU_GE_lTkiKhRDPW9rM7r1f8lllvFVhaPNMOq5bMf9Vx5i45RXDXZHfS8ydgdO7LjIJKUw_eKcVNwsRtmH7HSATrZltAH72Mg8lJWu0bFP4HDCfaXl6fQ4HkbWk7991objkabJ28sbrSvOIOuvy54Ii1EBMuS_TKcqvSZ5WiHpCxfZDQTP-ecw4PvRU6g4HDz7erm_enu3PQLaCLu55cgpVRPYpswhIqUEDulsY7-EmGmaVsG15Ir6Ozr6Xp_8z20gmg0nA9fwrcbOK5vFlStA83ye81v0daW9K7aoj81h4AV
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Fused+heterocyclic+kinase+inhibitors&rft.inventor=ZHEN-WEI+CAI&rft.inventor=ROBERT+M.+BORZILLERI&rft.inventor=WAYNE+VACCARO&rft.inventor=XIAO+TAO+CHEN&rft.inventor=TRAM+N.+HUYNH&rft.inventor=ZHONG+CHEN&rft.inventor=KYOUNG+S.+KIM&rft.date=2006-01-12&rft.externalDBID=A1&rft.externalDocID=AU2005260056A1